<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Tinos:ital,wght@0,400;0,700;1,400;1,700&display=swap"
        rel="stylesheet">

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Afacad+Flux:wght@100..1000&family=Tinos:ital,wght@0,400;0,700;1,400;1,700&display=swap"
        rel="stylesheet">

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,100;0,300;0,400;0,700;0,900;1,100;1,300;1,400;1,700;1,900&display=swap"
        rel="stylesheet">


    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Gemunu+Libre:wght@200..800&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="../css/nav.css">
    <link rel="stylesheet" href="../css/footer_2.css">
    <link rel="stylesheet" href="../css/about.css">

    <title> Cardiovascular | Biointercept </title>

</head>

<body>
    <!-- <div class="alert">
        <p>
            <strong>Under Maintenance: Updating Webpages</strong>
        </p>
    </div> -->
    <div class="header">
        <div class="logo">
            <a href="./index.html"> <img src="../assets/biointercept_logo.png" style="height: 16rem;" /> </a>
        </div>
        <div class="nav-links">
            <a href="../about.html" class="">WHO WE ARE</a>
            <a href="../research-areas" class="has-dropdown">RESEARCH AREAS</a>
            <a href="../technology-and-data.html" class="has-dropdown">TECHNOLOGY & DATA
                <!-- <span class="arrow-down"></span> -->
            </a>
            <a href="../resources.html">RESOURCES</a>
            <a href="../contact-us.html" class="contact-btn">CONTACT US</a>
        </div>
    </div>


    <h1> Cardiovascular </h1>
    <h3 class="subtitle-h3"><span class="subtitle-h3-blue">

            Innovative </span> Cardiovascular
        <span class="subtitle-h3-blue">

            Physiological </span> Research
        <span class="subtitle-h3-blue"> Expertise </span>

    </h3>


    <div class="hero-section">


        <div class="hero-image">
            <img src="./assets/cardio_page_pic.png" alt="Gene Illustration">
        </div>


        <div class="hero-content">



            <p>

Biointercept is at the forefront of cardiovascular innovation, leveraging cutting-edge genomics, AI-driven analytics,
and multi-omics integration to redefine the prevention and treatment of heart diseases. Our scientists employ advanced
techniques such as CRISPR-based gene editing, induced pluripotent stem cell (iPSC) modeling, and next-generation
sequencing to unravel the molecular mechanisms underlying conditions like recurrent pericarditis, coronary artery
disease (CAD), and genetic cardiomyopathies. By identifying disease-specific biomarkers and genetic variants, such as
those in *PCSK9* and *KCNQ1*, we enable the development of tailored therapies that address the root causes of
cardiovascular disorders while minimizing adverse effects and improving long-term outcomes.
<br /><br />
At Biointercept, we are pioneering precision medicine strategies that integrate genetic risk profiling with
real-world clinical data to optimize cardiovascular care. Our platforms utilize AI-powered algorithms to analyze
polygenic risk scores and predict individual susceptibility to conditions like CAD and arrhythmias, enabling proactive
intervention. Building on breakthroughs in gene therapy, we are developing one-time treatments targeting high-impact
genes, such as *PCSK9* inhibitors to permanently lower cholesterol and CRISPR-based therapies to correct mutations in
inherited cardiomyopathies. Additionally, our work with mRNA therapeutics, including VEGF-A encoding vaccines, aims to
enhance vascular repair and cardiac function, positioning Biointercept as a leader in next-generation cardiovascular
solutions.
<br /><br />
Biointercept is reshaping clinical research by implementing adaptive trial designs and advanced endpoints, such as
AI-enhanced cardiac imaging and digital health metrics, to accelerate drug development. Our expertise spans early-phase
studies to large-scale registrational trials, with a focus on complex conditions like heart failure and acute coronary
syndromes. Strategic collaborations with academic institutions and global health organizations enable us to integrate
novel approaches, including extracellular vesicle therapies and RNA-based modulators, into scalable treatment paradigms.
By combining rigorous trial methodologies with patient-specific iPSC models and real-world evidence, we are advancing
therapies that not only treat but also prevent cardiovascular diseases, solidifying our role as a catalyst for
transformative cardiac care.

                <br /><br />
                Our talented team at <span class="content-blue"> Biointercept Biotechnology </span>
                delivers high quality services to ensure you meet your targeted results.
             
            </p>

            <h3 class="subtitle-h3">
                Reach out to us to
                <span class="subtitle-h3-blue"> learn more: </span>
            </h3>
            <a href="../contact-us.html" class="button">CONTACT US</a>
        </div>


    </div>
    <footer class="footer">
        <hr class="footer-divider">

        <div class="footer-content">
            <div class="footer-info">
                <p><strong>Biointercept Biotechnology Inc.</strong></p>

            </div>

            <div class="footer-links">
                <p>Â© 2025 Biointercept, All Rights Reserved |
                    <a href="../maintenance.html">Privacy Policy</a> |
                    <a href="../maintenance.html">Accessibility Statement</a> |

                    <a href="../maintenance.html">Terms of Use</a> |
                    <a href="../maintenance.html">Sitemap</a>
                </p>
            </div>

            <div class="social-icons">
                <a href="../maintenance.html" class="fa fa-facebook"></a>
                <a href="https://www.linkedin.com/company/Biointercept-biotech/" class="fa fa-linkedin"></a>

            </div>
        </div>
    </footer>


</body>

</html>